AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
A new study published in Nutrients offers new insight into omega-6 and whether it is truly the proinflammatory fatty acid ...
Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...
Credit: JCI Insight (2025). DOI: 10.1172/jci.insight.184975 The sCD13 protein has been previously identified by a rheumatology research team at the ...
A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, ...
Credit: Cell Reports (2025). DOI: 10.1016/j.celrep.2025.115294 A better understanding of inflammation and lung immunity over the past two decades has ...
Gilead Sciences’ inflammation drug prospects have come via deals, and the latest one brings drug candidates for an elusive target ...
A recently published study led by Wayne State University on a new approach to understanding chronic inflammation could lead to ...
Could managing COPD symptoms be as simple as taking a daily vitamin? A new study suggests it might be, as ...
Credit: Unsplash/CC0 Public Domain Investigators recently uncovered key insights into newly defined rejection entities in kidney transplantation that may offer ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.